New

From idea to ETF portfolio in minutes. Build yours now →

Advertisement
Advertisement

ARKGvsXHEETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.01%
VS
ETF 2
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0.5%

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. State Street SPDR S&P Health Care Equipment ETF (XHE) is part of the US Health Care segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, XHE's top sector exposures are Health Care  ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.35% for XHE. ARKG is down -2.36% year-to-date (YTD) with -$17M in YTD flows. XHE performs worse with -7.32% YTD performance, and -$12M in YTD flows. Run a side-by-side ETF comparison of ARKG and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs XHE performance and flow charts

Performance

0510152025%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-80 M-60 M-40 M-20 M0 M20 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
XHE
+14.98%+3.90%
-9.13%-5.37%
-2.36%-7.32%
+27.92%+3.60%
-2.43%-16.69%
-67.96%-34.99%
Flows
ARKG
XHE
-$2M-$10M
-$53M-$8M
-$17M-$12M
-$66M-$41M
-$583M-$308M
-$3.03B-$410M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
XHE
+43.08%+25.14%
+41.66%+21.83%
+42.62%+21.49%
+45.37%+24.41%
Max drawdown
ARKG
XHE
-20.97%-14.31%
-27.52%-18.20%
-51.98%-32.46%
-80.16%-49.90%
Max drawdown duration
ARKG
XHE
90d64d
97d113d
1015d1019d
1765d1702d
Trading data

Create an account to view trading data

Join for free
ARKG
XHE
Last sale
5/1/2026 at 1:30 PM
$30.30
$81.67
Previous close
04/29/2026
$29.87
$80.33
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of April 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
XHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 5/1/2026 at 1:30 PM
Live
Closed
ARKG
XHE
Last price
$30.30
$81.67
1D performance
+1.44%
+1.67%
AuM$1.13 B$130.68 M
E/R0.75%0.35%
Characteristics
ARKG
XHE
Management strategyActivePassive
ProviderArk InvestmentState Street Investment Management
Benchmark-S&P Health Care Equipment Select Industry Index
N° of holdings2761
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019January 26, 2011
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
70.4%
Switzerland
9.23%
Other
20.37%
XHE
USA
92.19%
Other
7.81%

Sectors

ARKG
Health Care
78.38%
Other
21.62%
XHE
Health Care
89.87%
Other
10.13%
Advertisement

Diversification

ARKG

Total weight of top 15 holdings out of 15

62.5%
XHE

Total weight of top 15 holdings out of 15

26.74%

Top 15 holdings

Data as of March 31, 2026
ARKG
CRISPR THERAPEUTICS
9.23%
10X GENOMICS INC
6.30%
BEAM THERAPEUTICS
4.86%
PERSONALIS INC
4.69%
NATERA
4.48%
ILLUMINA
4.45%
GUARDANT HEALTH INC
4.21%
INTELLIA THERAPEUTICS INC
3.58%
CAREDX INC/D
3.56%
RECURSION PHARMACEUTICALS
3.54%
ABSCI
3.27%
VERACYTE INC/D
2.98%
ADAPTIVE BIOTECHNOLOGIES
2.71%
NURIX THERAPEUTICS
2.45%
SEMA4 HOLDINGS CORP
2.19%
XHE
TELEFLEX
1.86%
STAAR SURGICAL
1.84%
BUTTERFLY NETWORK INC
1.84%
US58507V1070
1.83%
GLAUKOS
1.82%
INTEGER HOLDINGS
1.79%
AXOGEN
1.79%
LIVANOVA
1.78%
MASIMO
1.76%
LEMAITRE VASCULAR
1.75%
ARTIVION INC
1.75%
HOLOGIC
1.74%
STERIS
1.74%
GLOBUS MEDICAL
1.72%
IRHYTHM TECHNOLOGIES
1.72%
Frequently asked questions about ARKG and XHE

How have the ARKG and XHE ETFs performed in 2026?

As of April 29, 2026, ARKG is down -2.36% year-to-date (YTD), while XHE has lost -7.32%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or XHE?

Year-to-date, the ARKG ETF saw -$17M in flows, compared to -$12M for XHE.

Which ETF is more volatile: ARKG or XHE?

Over the past year, ARKG had a volatility of 41.66%, while XHE experienced 21.83%.

Which ETF is bigger: ARKG or XHE?

As of April 29, 2026, ARKG holds $1.13 B in assets under management (AUM), while XHE manages $130.68 M.

What sectors do the ARKG and XHE ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, XHE focuses on Health Care.

What are the top holdings of the ARKG ETF and XHE ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. XHE holds in its top three: TELEFLEX, STAAR SURGICAL and BUTTERFLY NETWORK INC.

Which ETF is more diversified: ARKG or XHE?

ARKG holds 27 securities with 62.5% of its assets in the top 15. XHE has 67 securities and a top 15 weight of 26.74%.

Advertisement
Latest news about ARKG & XHE
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up